Support for TrkB-FL processing being secondary also came from dynasore inhibition of dynamin-dependent endocytosis, which resulted in TrkB-FL stabilization during excitotoxicity (Fig. 1E, F), as previously demonstrated in ischemia [8]. The gene discussed is DNM1; the disease is ischemia.